Current Status and Future Direction of PET/MR in Cardiology

Extracorporeal Shockwave Therapy in Cardiology: Current Status and Future Perspectives

Management of end-stage coronary artery disease is often hopeless because of lack of evidence-based, uniformly effective, safe, and inexpensive treatment options. Geneor stem-cell-based therapies are not yet ready for routine clinical use, and heart transplantation is seriously limited by the scarcity of organs. In this regard, extracorporeal shockwave therapy is emerging as a noninvasive means...

Current Status and Future Direction of the Monk Software Package

The MONK user package comprises not only the Monte Carlo code itself but also nuclear data libraries, validation data, documentation, geometry model visualisation tools, productivity tools of various kinds and user support services. In identifying the development direction for the package, input is obtained not only from the two collaborating partners but also from others customers of the ANSWE...

The current status and future direction of fetal gene therapy

Anna L David, Michael Themis, Simon N Waddington, Lisa Gregory, Suzanne MK Buckley, Megha Nivsarkar, Terry Cook, Donald Peebles, Charles H Rodeck, Charles Coutelle Department of Obstetrics and Gynaecology, Royal Free and University College London Medical School, London WC1E 6HX Gene Therapy Research Group, Section of Cell and Molecular Biology, Division of Biomedical Sciences, Imperial College ...

Current Status and Future Direction of Transcatheter Mitral Valve Replacement

The current status and future of theranostic Copper-64 radiopharmaceuticals

Copper-64 was produced in large scales and high specific activities in late 1990s’ using compact cyclotrons based by 64Ni(p,n)64Cu reaction and many radiopharmaceuticals developed since then by various groups based on interesting physicochemical and nuclear properties of the radionuclide. The unique emission of beta particles as well as positron particles offers a spectacu...